CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-17 | Brownlie Keith L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2021-06-17 | PENNER HARRY JR Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2021-06-17 | Shoos Karen L. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2021-06-17 | CONRAD HERBERT J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2021-06-17 | MARINO JAMES J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2020-12-14 | Wright Richard M. Sr. VP & CCO | Option exercise | +11,457 | $9.02 | $103K | 11,665 |
| 2020-12-14 | Wright Richard M. Sr. VP & CCO | Sale | −11,457 | $18.61 | $213K | 208 |
| 2020-12-14 | Wright Richard M. Sr. VP & CCO | Option exercise | +9,375 | $2.78 | $26K | 9,583 |
| 2020-12-14 | Wright Richard M. Sr. VP & CCO | Sale | −9,375 | $18.61 | $174K | 208 |
| 2020-12-14 | Wright Richard M. Sr. VP & CCO | Option exercise · Incentive Stock Option | −11,457 | 6,876 | ||
| 2020-12-14 | Wright Richard M. Sr. VP & CCO | Option exercise · Incentive Stock Option | −9,375 | 20,625 | ||
| 2020-06-18 | Martin Samuel Bates SVP and CFO | Grant or award · Incentive Stock Option (right to buy) | +105,600 | 105,600 | ||
| 2020-06-18 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Grant or award · Incentive Stock Option (right to buy) | +84,000 | 84,000 | ||
| 2020-06-18 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Grant or award · Incentive Stock Option (right to buy) | +84,000 | 84,000 | ||
| 2020-06-18 | Crowley Elizabeth Sr. VP &CPDO | Grant or award · Incentive Stock Option (right to buy) | +84,000 | 84,000 | ||
| 2020-06-18 | PEPIN RONALD Sr. VP & CBO | Grant or award · Incentive Stock Option (right to buy) | +14,400 | 14,400 | ||
| 2020-06-18 | Wright Richard M. Sr. VP & CCO | Grant or award · Incentive Stock Option (right to buy) | +42,000 | 42,000 | ||
| 2020-06-18 | Young Diane C. SVP, Chief Medical Officer | Grant or award · Incentive Stock Option (right to buy) | +72,000 | 72,000 | ||
| 2020-06-18 | KELER TIBOR Executive VP & CSO | Grant or award · Incentive Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2020-06-18 | Marucci Anthony S President & CEO | Grant or award · Incentive Stock Option (right to buy) | +245,000 | 245,000 |
Page 14 of 17 · 325 trades